Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5d62b24bd9ee041f521ff3177003b86 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-59 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-277 |
filingDate |
2002-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ccd7b873fd5cb824b5ab694c7ce0442 |
publicationDate |
2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-PA04007183-A |
titleOfInvention |
PHARMACEUTICAL COMPOSITION FOR THE CONTROL OF GLUCOSE IN BLOOD OF PATIENTS WITH TYPE 2 DIABETES. |
abstract |
Pharmaceutical compositions of the active substances Glimepiride and Metformin or their salts such as hydrochloride, succinate fumarate, etc. are provided. for the control of blood glucose in patients with type 2 diabetes. To test the effectiveness of the combination, clinical studies were conducted that proved that there is not only an additive effect of the two drugs but also synergistic, compared to monotherapy using only some of the drugs of the combination. Consequently, the use of the combination is proposed as an effective and safe therapy for blood glucose control of patients with type 2 diabetes using different proportions of the active substances in the combinations, to adapt to the different needs of the patients. |
priorityDate |
2002-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |